Consistently, AlloCAR70-NKT cells also exhibited robust cytotoxicity against CD70-knockout RCC tumor cells, including 786-O-FG engineered by CRISPR/Cas9, further supporting that their antitumor activity is partially mediated through NKR-dependent mechanisms.1 This evidence concerns the gene CD70 and renal cell carcinoma.